Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.

Baltch AL, Lawrence D, Ritz WJ, Andersen N, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Chemotherapy. 2012;58(2):146-51. doi: 10.1159/000337076. Epub 2012 May 12.

PMID:
22584412
2.

Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.

Baltch AL, Lawrence DA, Ritz WJ, Andersen NJ, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):226-33. doi: 10.1016/j.diagmicrobio.2011.11.004. Epub 2011 Dec 29.

PMID:
22209510
3.

Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5 Candida species.

Bopp LH, Baltch AL, Ritz WJ, Smith RP.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):320-2. doi: 10.1016/j.diagmicrobio.2011.08.001. Epub 2011 Sep 19.

PMID:
21937187
4.

Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.

Smith RP, Baltch A, Bopp LH, Ritz WJ, Michelsen PP.

Diagn Microbiol Infect Dis. 2011 Oct;71(2):131-8. doi: 10.1016/j.diagmicrobio.2011.06.018. Epub 2011 Aug 23.

PMID:
21865002
5.

Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.

Baltch AL, Ritz W, Bopp LH, Michelsen PB, Smith RP.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):468-74. doi: 10.1016/j.diagmicrobio.2011.04.008.

PMID:
21767703
6.

Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.

Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP.

Diagn Microbiol Infect Dis. 2011 Jan;69(1):86-93. doi: 10.1016/j.diagmicrobio.2010.08.023.

PMID:
21146719
7.

IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics.

Smith RP, Baltch AL, Ritz WJ, Michelsen PB, Bopp LH.

Cytokine. 2010 Sep;51(3):274-7. doi: 10.1016/j.cyto.2010.06.004. Epub 2010 Jun 30.

PMID:
20580568
8.
9.
10.

Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.

Baltch AL, Bopp LH, Ritz WJ, Michelsen PB, Yan SB, Um S, Smith RP.

J Antimicrob Chemother. 2007 Jun;59(6):1177-81. Epub 2007 Apr 11.

PMID:
17428810
12.

Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.

Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP.

J Med Microbiol. 2006 Jul;55(Pt 7):865-70.

PMID:
16772413
13.
14.
15.

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.

Baltch AL, Smith RP, Ritz WJ, Carpenter AN, Bopp LH, Michelsen PB, Carlyn CJ, Hibbs JR.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):205-12.

PMID:
15541607
16.

In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.

Smith RP, Baltch AL, Ritz WJ, Carpenter AN, Halse TA, Bopp LH.

Antimicrob Agents Chemother. 2004 Jun;48(6):2081-4.

17.

Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.

Baltch AL, Smith RP, Ritz WJ, Carpenter-Knaggs A, Michelsen PB, Carlyn CJ, Bopp LH, Hibbs JR.

Chemotherapy. 2003 May;49(1-2):27-32.

PMID:
12714806
19.

Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

Baltch AL, Smith RP, Franke MA, Ritz WJ, Michelsen PB, Bopp LH.

Antimicrob Agents Chemother. 2001 Jan;45(1):96-104.

20.

Microbicidal activity of MDI-P against Candida albicans, Staphylococcus aureus, Pseudomonas aeruginosa, and Legionella pneumophila.

Baltch AL, Smith RP, Franke MA, Ritz WJ, Michelsen P, Bopp LH, Singh JK.

Am J Infect Control. 2000 Jun;28(3):251-7. Review.

PMID:
10840346
21.

Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa.

Smith RP, Baltch AL, Franke MA, Michelsen PB, Bopp LH.

J Antimicrob Chemother. 2000 Apr;45(4):483-8.

PMID:
10747825
22.

Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.

Stevens RW, Baltch AL, Smith RP, McCreedy BJ, Michelsen PB, Bopp LH, Urnovitz HB.

Clin Diagn Lab Immunol. 1999 Nov;6(6):783-6.

23.

Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State.

Bopp LH, Schoonmaker DJ, Baltch AL, Smith RP, Ritz WJ.

Am J Infect Control. 1999 Oct;27(5):411-7.

PMID:
10511488
25.

Comparison of restriction enzyme analysis, arbitrarily primed PCR, and protein profile analysis typing for epidemiologic investigation of an ongoing Clostridium difficile outbreak.

Rafferty ME, Baltch AL, Smith RP, Bopp LH, Rheal C, Tenover FC, Killgore GE, Lyerly DM, Wilkins TD, Schoonmaker DJ, Hannett GE, Shayegani M.

J Clin Microbiol. 1998 Oct;36(10):2957-63.

26.

Genetic analysis of multiple vancomycin-resistant Enterococcus isolates obtained serially from two long-term-care patients.

Schoonmaker DJ, Bopp LH, Baltch AL, Smith RP, Rafferty ME, George M.

J Clin Microbiol. 1998 Jul;36(7):2105-8.

27.

Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay.

Rafferty ME, McCormick MI, Bopp LH, Baltch AL, George M, Smith RP, Rheal C, Ritz W, Schoonmaker D.

Infect Control Hosp Epidemiol. 1997 May;18(5):342-4.

PMID:
9154478
28.

Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Bopp LH, Baltch AL, Hammer MC, Franke MA, Smith RP, Lutz F.

Infect Immun. 1991 Feb;59(2):708-11.

29.

DNA probes for the identification of Haemophilus ducreyi.

Parsons LM, Shayegani M, Waring AL, Bopp LH.

J Clin Microbiol. 1989 Jul;27(7):1441-5.

30.

Biological approaches for polychlorinated biphenyl degradation.

Unterman R, Bedard DL, Brennan MJ, Bopp LH, Mondello FJ, Brooks RE, Mobley DP, McDermott JB, Schwartz CC, Dietrich DK.

Basic Life Sci. 1988;45:253-69. No abstract available.

PMID:
3140775
31.

Rapid assay for screening and characterizing microorganisms for the ability to degrade polychlorinated biphenyls.

Bedard DL, Unterman R, Bopp LH, Brennan MJ, Haberl ML, Johnson C.

Appl Environ Microbiol. 1986 Apr;51(4):761-8.

32.

Cloning of a Thiobacillus ferrooxidans plasmid in Escherichia coli.

Holmes DS, Lobos JH, Bopp LH, Welch GC.

J Bacteriol. 1984 Jan;157(1):324-6.

33.

Chromate resistance plasmid in Pseudomonas fluorescens.

Bopp LH, Chakrabarty AM, Ehrlich HL.

J Bacteriol. 1983 Sep;155(3):1105-9.

34.
35.

Contact inactivation of RNA and DNA viruses by N-methyl isatin beta-thiosemicarbazone and CuSO4.

Fox MP, Bopp LH, Pfau CJ.

Ann N Y Acad Sci. 1977 Mar 4;284:533-43. No abstract available.

PMID:
212986

Supplemental Content

Support Center